Internal Medicine, Nephrology · Peoria, AZ
NPI
1568760502
Since 2011
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
7362 W Thunderbird Rd
Peoria, AZ, 85381
Phone (480) 610-6100
Groups this clinician bills Medicare through
Medicare paid, 2024
$256K
7,632 services
Medicare patients, 2024
780
Average age 77
Drug cost, 2024
$3.0M
5,638 prescriptions
Company payments, 2025
$100K
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Minesh Rajpal was code 99214 (office e&m - established), 858 times for 409 patients. In total Minesh Rajpal billed 7,632 services in 43 codes, and Medicare paid $256K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-11-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 858 | 409 | $88.38 | $76K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 844 | 406 | $12.16 | $10K |
| 99233 Hospital E&M - Subsequent | Facility | 794 | 281 | $87.63 | $70K |
| 80069 Clinical Chemistry | Office | 560 | 277 | $8.44 | $4,727 |
| 84156 Clinical Chemistry | Office | 471 | 247 | $3.57 | $1,682 |
| 82570 Clinical Chemistry | Office | 462 | 245 | $5.04 | $2,328 |
| 85027 Blood Count | Office | 386 | 228 | $6.32 | $2,441 |
| 36415 Venipuncture Blood Collection | Office | 356 | 202 | $5.88 | $2,093 |
| 83735 Clinical Chemistry | Office | 316 | 167 | $6.57 | $2,076 |
| 83970 Clinical Chemistry | Office | 298 | 177 | $40.31 | $12K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 295 | 73 | $48.27 | $14K |
| 84550 Clinical Chemistry | Office | 237 | 137 | $4.43 | $1,050 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 191 | 75 | $36.95 | $7,057 |
| 99223 Hospital E&M - Initial | Facility | 180 | 166 | $128.49 | $23K |
| 82652 Clinical Chemistry | Office | 143 | 90 | $37.73 | $5,395 |
By year: 2022 $253K for 9,001 services; 2023 $234K for 6,688 services; 2024 $256K for 7,632 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80069 Clinical Chemistry | 560 | 277 | $8.44 | $4,727 |
| 84156 Clinical Chemistry | 471 | 247 | $3.57 | $1,682 |
| 82570 Clinical Chemistry | 462 | 245 | $5.04 | $2,328 |
| 85027 Blood Count | 386 | 228 | $6.32 | $2,441 |
| 36415 Venipuncture Blood Collection | 356 | 202 | $5.88 | $2,093 |
| 83735 Clinical Chemistry | 316 | 167 | $6.57 | $2,076 |
| 83970 Clinical Chemistry | 298 | 177 | $40.31 | $12K |
| 84550 Clinical Chemistry | 237 | 137 | $4.43 | $1,050 |
| 82652 Clinical Chemistry | 143 | 90 | $37.73 | $5,395 |
| 85025 Blood Count | 63 | 61 | $7.50 | $472 |
Medicare prescription drug claims, 2024
In 2024, the drug Minesh Rajpal prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 1,068 prescriptions and refills. In total Minesh Rajpal wrote 5,638 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | 1,068 | 2,274 | 270 | $1.2M |
| Losartan Potassium Generic | 451 | 1,301 | 139 | $4,931 |
| Kerendia Finerenone | 344 | 634 | 81 | $396K |
| Amlodipine Besylate Generic | 312 | 876 | 97 | $2,120 |
| Allopurinol Generic | 293 | 855 | 85 | $2,839 |
| Lisinopril Generic | 243 | 667 | 76 | $1,928 |
| Furosemide Generic | 237 | 668 | 75 | $1,417 |
| Jardiance Empagliflozin | 211 | 423 | 64 | $233K |
| Fluconazole Generic | 181 | 406 | 56 | $8,369 |
| Tamsulosin Hcl Generic | 169 | 450 | 46 | $2,557 |
| Calcitriol Generic | 166 | 486 | 51 | $5,113 |
| Torsemide Generic | 106 | 308 | 41 | $1,985 |
| Hydralazine Hcl Generic | 97 | 248 | 33 | $1,553 |
| Spironolactone Generic | 92 | 266 | 30 | $1,243 |
| Prednisone Generic | 88 | 235 | 31 | $688 |
Brand drugs: 1,875 claims; generic drugs: 3,763 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Minesh Rajpal $100K ($100K in general payments such as food, travel and fees) from 22 companies. The largest payer was Akebia Therapeutics Inc with $27K.
| Company | Payments | Amount |
|---|---|---|
| Akebia Therapeutics Inc AKBA | 51 | $27K |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 32 | $20K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 17 | $19K |
| Amgen Inc. AMGN | 31 | $14K |
| Lilly USA, LLC LLY | 10 | $11K |
| AstraZeneca Pharmaceuticals LP AZN | 14 | $6,425 |
| Novo Nordisk Inc NVO | 7 | $153 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 6 | $133 |
| Vantive US Healthcare LLC | 1 | $128 |
| Travere Therapeutics, Inc. TVTX | 3 | $80.13 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.